1. Home
  2. WST vs STM Comparison

WST vs STM Comparison

Compare WST & STM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • STM
  • Stock Information
  • Founded
  • WST 1923
  • STM 1987
  • Country
  • WST United States
  • STM Netherlands
  • Employees
  • WST N/A
  • STM N/A
  • Industry
  • WST Medical/Dental Instruments
  • STM Semiconductors
  • Sector
  • WST Health Care
  • STM Technology
  • Exchange
  • WST Nasdaq
  • STM Nasdaq
  • Market Cap
  • WST 18.9B
  • STM 28.2B
  • IPO Year
  • WST N/A
  • STM 1994
  • Fundamental
  • Price
  • WST $258.04
  • STM $26.98
  • Analyst Decision
  • WST Buy
  • STM Buy
  • Analyst Count
  • WST 7
  • STM 7
  • Target Price
  • WST $332.50
  • STM $36.75
  • AVG Volume (30 Days)
  • WST 575.5K
  • STM 6.1M
  • Earning Date
  • WST 10-23-2025
  • STM 10-30-2025
  • Dividend Yield
  • WST 0.35%
  • STM 1.18%
  • EPS Growth
  • WST N/A
  • STM N/A
  • EPS
  • WST 6.68
  • STM 0.71
  • Revenue
  • WST $2,960,200,000.00
  • STM $11,855,000,000.00
  • Revenue This Year
  • WST $6.28
  • STM N/A
  • Revenue Next Year
  • WST $6.02
  • STM $12.98
  • P/E Ratio
  • WST $37.92
  • STM $35.64
  • Revenue Growth
  • WST 2.90
  • STM N/A
  • 52 Week Low
  • WST $187.43
  • STM $17.25
  • 52 Week High
  • WST $352.33
  • STM $33.47
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.88
  • STM 52.87
  • Support Level
  • WST $253.38
  • STM $25.87
  • Resistance Level
  • WST $264.06
  • STM $27.06
  • Average True Range (ATR)
  • WST 5.62
  • STM 0.59
  • MACD
  • WST 0.67
  • STM 0.06
  • Stochastic Oscillator
  • WST 73.15
  • STM 62.73

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About STM STMicroelectronics N.V.

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.

Share on Social Networks: